{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:19:23Z","timestamp":1762928363438},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejphar.2015.04.042","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T20:54:53Z","timestamp":1430772893000},"page":"383-390","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi"],"prefix":"10.1016","volume":"761","author":[{"given":"Paola","family":"Rogliani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josuel","family":"Ora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Lipsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Segreti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.04.042_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2040622313518227","article-title":"Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases","volume":"5","author":"Alagha","year":"2014","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.ejphar.2015.04.042_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.113.204644","article-title":"Effect of the mixed phosphodiesterase 3\/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone","volume":"346","author":"Calzetta","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.04.042_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2014.10.025","article-title":"Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi","volume":"745","author":"Cazzola","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.042_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1165\/rcmb.2011-0449OC","article-title":"High glucose enhances responsiveness of human airways smooth muscle via the Rho\/ROCK pathway","volume":"47","author":"Cazzola","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2015.04.042_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/15412555.2014.922172","article-title":"Translational study searching for synergy between glycopyrronium and indacaterol","volume":"12","author":"Cazzola","year":"2014","journal-title":"COPD"},{"key":"10.1016\/j.ejphar.2015.04.042_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.rmed.2004.05.003","article-title":"The functional impact of adding salmeterol and tiotropium in patients with stable COPD","volume":"98","author":"Cazzola","year":"2004","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejphar.2015.04.042_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pupt.2003.09.001","article-title":"The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD","volume":"17","author":"Cazzola","year":"2004","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.04.042_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2015.04.042_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/20734735.014813","article-title":"Long-acting bronchodilators in COPD: where are we now and where are we going?","volume":"10","author":"Cazzola","year":"2014","journal-title":"Breathe"},{"key":"10.1016\/j.ejphar.2015.04.042_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1517\/14656566.2013.776539","article-title":"Aclidinium bromide\/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease","volume":"14","author":"Cazzola","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2015.04.042_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2015.04.042_bib12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.rmed.2011.02.020","article-title":"Bronchodilator responsiveness and onset of effect with budesonide\/formoterol pMDI in COPD","volume":"105","author":"Celli","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejphar.2015.04.042_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1081\/COPD-200053377","article-title":"Minimal clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.ejphar.2015.04.042_bib14","first-page":"H655","article-title":"Contractile properties of isolated vascular smooth muscle after photoradiation","volume":"256","author":"Freas","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2015.04.042_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/jpet.109.151639","article-title":"Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile","volume":"331","author":"Gavalda","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.04.042_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pupt.2014.05.005","article-title":"The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide","volume":"28","author":"Gavalda","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.04.042_bib17","unstructured":"GINA, 2011. Global Initiative for Asthma. Guidelines: Global Strategy for Asthma Management And Prevention (GINA). Available from: \u3008http:\/\/www.ginasthma.com\u3009 (accessed 31.01.15)."},{"key":"10.1016\/j.ejphar.2015.04.042_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198408163110701","article-title":"Role of the parasympathetic system in airway obstruction due to emphysema","volume":"311","author":"Gross","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.04.042_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0702573","article-title":"Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways","volume":"127","author":"Haddad","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.042_bib20","first-page":"61","article-title":"Ethanol suppresses l-arginine-induced relaxation response of rat aorta stimulated with bacterial lipopolysaccharide","volume":"35","author":"Hatake","year":"2000","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"},{"key":"10.1016\/j.ejphar.2015.04.042_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/COPD.S48967","article-title":"Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis","volume":"8","author":"Karabis","year":"2013","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.ejphar.2015.04.042_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1183\/09031936.00040712","article-title":"Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study","volume":"40","author":"Kerwin","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2015.04.042_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinthera.2005.04.006","article-title":"Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease","volume":"27","author":"Koumis","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2015.04.042_bib24","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1183\/09031936.95.08091506","article-title":"Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group","volume":"8","author":"Maesen","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2015.04.042_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tips.2011.04.003","article-title":"Novel bronchodilators for the treatment of chronic obstructive pulmonary disease","volume":"32","author":"Matera","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2015.04.042_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1517\/14656566.2014.899581","article-title":"Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease","volume":"15","author":"Matera","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2015.04.042_bib27","first-page":"3","article-title":"Functional profile of aclidinium bromide in isolated human bronchi and left atria","volume":"1","author":"Milara","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.ejphar.2015.04.042_bib28","first-page":"859","article-title":"An assessment of the functional profile of aclidinium in human bronchi and left atria","volume":"38","author":"Milara","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2015.04.042_bib29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000091996","article-title":"Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD","volume":"73","author":"Richter","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.ejphar.2015.04.042_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pupt.2013.01.002","article-title":"The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle","volume":"26","author":"Rogliani","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.04.042_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/mol.108.054452","article-title":"Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor","volume":"76","author":"Sykes","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.042_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/jpet.112.194456","article-title":"The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium","volume":"343","author":"Sykes","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.04.042_bib33","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1164\/ajrccm.150.6.7952627","article-title":"Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways","volume":"150","author":"Takahashi","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2015.04.042_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1465-9921-11-149","article-title":"Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents","volume":"11","author":"Tashkin","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2015.04.042_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.55.4.289","article-title":"A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease","volume":"55","author":"van Noord","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2015.04.042_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1183\/09031936.02.00238002","article-title":"Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease","volume":"19","author":"van Noord","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2015.04.042_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/15412555.2010.510158","article-title":"Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD","volume":"7","author":"Vestbo","year":"2010","journal-title":"COPD"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915004045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915004045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T21:57:07Z","timestamp":1691618227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915004045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":37,"alternative-id":["S0014299915004045"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.042","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}